MCUJ - Company update for commercial development and clinical development of AGGRASTAT likely around the corner. Easily $0.10 on low volume. Possible $0.40, or more, on increased investor awareness, depend upon the strength of the company's update.
Please research all stocks before investing. My posts are my opinions and are not buy or sell recommendations. Always force abusive short sellers to cover above what you paid. Build wealth for fellow iHub'ers!